The ACR has approved a set of evidence-based quality measures aimed at improving care and drug safety for patients with rheumatoid arthritis, osteoporosis, and gout.
Search results for: gout
If Joe the Plumber Gets Arthritis
Campaign figure’s connection to personalized medicine
Quality Measures and Reporting
A call for professional responsibility
Research and the Economic “Big One”
The fortunes of industry and academia may rise and fall together
Quality Advice from Specialty Societies
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies
Study Groups: Where Information and Networking Mix
ACR study groups provide an excellent forum for networking at the ACR/ARHP Annual Scientific Meeting and are among the most highly sought-after sessions each year. Although study groups are not eligible for CME credits, they provide an opportunity for the exchange of new ideas and in-depth presentations of information. These groups give attendees the opportunity to discuss cases and share experiences with colleagues who share a common interest in one disease, a group of related disorders, or a specialized field of study.
Reading Rheum: Lumbar Spinal Stenosis
Handpicked Reviews of Contemporary Literature
FDA Enforcement Against Injectable Colchicine
The U.S. Food and Drug Administration (FDA) has ordered companies to stop marketing unapproved drug products that contain colchicines in an injectable dosage form.
Reading Rheum: Which Bone Agent Is Best in High-risk Osteoporosis?
Handpicked Reviews of Contemporary Literature
Rheumatology’s Divergent Thinkers
OMERACT selects outcomes measures with an egalitarian process